Mayur Ian Somaiya - Dec 29, 2023 Form 3 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role
Chief Financial Officer
Signature
/s/ Louise Kooij by Power of Attorney for Mayur Ian Somaiya
Stock symbol
NAMS
Transactions as of
Dec 29, 2023
Transactions value $
$0
Form type
3
Date filed
12/29/2023, 04:30 PM
Next filing
Jan 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NAMS Option (right to buy) Dec 29, 2023 Ordinary Shares 825K $9.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on November 1, 2023. 25% of the shares underlying the option will vest on the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.

Remarks:

Exhibit List: Exhibit 24.1 - Power of Attorney